NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Market Analysis on Molecular Diagnostics in Healthcare (pre-order)

出版商 M14 Intelligence Research Pvt. Ltd. 商品編碼 919020
出版日期 內容資訊 英文
商品交期: 請詢問到貨日
醫療用分子診斷的全球市場分析 Market Analysis on Molecular Diagnostics in Healthcare (pre-order)
出版日期: 2019年12月02日內容資訊: 英文


第1章 摘要整理

第2章 分析範圍、手法

第3章 分子診斷:產業趨勢的變化

  • 在精密醫療產業的分子診斷的普及率上升
  • 隨著技術進步,在新興國家的分子診斷的需求增加

第4章 醫療用分子診斷市場:近來的有機、無機發展的動向

  • 無機發展:企業合併、收購 (M&A),投資,融資,事業合作

第5章 FDA (美國食品藥物管理局)的法規、規定:分子診斷市場阻礙因素

第6章 分子診斷的應用領域:感染疾病,腫瘤,遺傳基因檢驗,血液檢驗

第7章 分子診斷技術分析

  • PCR (聚合酵素鏈鎖反應) 技術:迅速、廉價的DNA擴增手段
  • FISH (螢光原位雜合):為了探知染色體內部特定的DNA序列的技術
  • 定序 (DNA/NGS):基因學、蛋白質體學、轉錄體學、代謝體學的利用
  • 微陣列技術:疾病相關的遺傳基因/病原體的判斷 (基因型鑑定)
  • INAAT (核酸等溫放大技術):臨床的巨大需求
  • 其他:電泳,質譜分析,流式細胞技術

第8章 競爭力的評估:分子診斷市場競爭環境

  • 大企業的產品、服務:市場佔有率分析
  • 各地區市場佔有率結構
  • 各企業的最新技術:分子診斷市場
  • 近來的資本交易趨勢:事業聯盟、合作,企業合併、收購 (M&A),融資等
  • 主要的分析對象企業:Roche Diagnostics,Qiagen,Becton Dickinson (BD),Abbott Laboratories,Hologic (含Gen-Probe),Agilent Technologies,Cepheid,Siemens Healthcare,BioMerieux,Quest Diagnostics Incorporated

第9章 附錄


M14 Intelligence expertise in precision medicine industry is a leverage of its multiple years of data-evaluation of emerging healthcare technologies. Our team of 2 consultants and 1 subject matter expert of molecular diagnostic technology has been tracking and evaluation the changing dynamics of the industry.

  • The report gives detailed analysis on the changing dynamics, emerging trends, and market opportunities of molecular diagnostics market.
  • The report covers analysis on historical market trend, and market forecast of molecular diagnostics market.
  • The report analyzes the expected future demand of molecular diagnostics and factors that are defining this expected demand.
  • A deep investigation into Molecular diagnostics industry and detailed analysis on its
  • Applications such as Infectious diseases, Oncology, Genetic Testing, Blood Screening
  • Microbiology and Neurological Diseases.
  • Technology such as- Polymerase Chain Reaction (PCR), Hybridization, Sequencing
  • (DNA & NGS), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT)

Electrophoresis, Mass spectroscopy, Flow Cytometry. Demand for Molecular diagnostics is analysed across different end users such as hospitals, laboratories, pharmaceuticals and biotechnology industries, clinical diagnostics, centres, universities and research organisations which is mentioned in this report.

Molecular Technologies that are analysed are Polymerase Chain Reactions (PCR), Hybridization, Sequencing (DNA & NGS), Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Electrophoresis, Mass Spectroscopy, Flow Cytometry.

Leading companies and new entrants in the market are analysed for their revenue, product and service offerings.

The detailed survey on inorganic developments such as partnerships, mergers & acquisition, collaboration and organic developments are mentioned in this report.

Companies offering Molecular Diagnostics Technology mentioned in the report are: Roche Diagnostics, Qiagen, Becton Dickinson (BD), Abbott Laboratories, Hologic, Agilent Technologies, Cepheid, Siemens Healthcare, BioMerieux, Quest Diagnostics Incorporated, Johnson and Johnson, GenMark diagnostics, Alere Inc., Analytik Jena, Danaher Corporation, Illumina, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Biocartis Group NV, HiberGene Diagnostics, Celtic Molecular Diagnostics (Pty) Ltd., Laboratory Corporation of America Holdings, DNA Diagnostics Center, Elitechgroup, GE Healthcare, Inc., Genomic Health, Inc., Agendia NV, Luminex Corporation, Oxford Gene Technology, Savyon Diagnostics, Seegene Inc, Transgenomic Inc., Kaneka Eurogentec S.A, Milliporesigma, Myriad Genetics, Inc, Origene Technologies, Inc., Ortho Clinical Diagnostics, Perkinelmer Inc., Promega Corporation, Sorenson Genomics, LLC, Sysmex Inostics GmbH, Wuxi Nextcode, Grifols, Diasorin, 10X Genomics, Bristol-Myers Squibb, Foundation Medicine, HTG Molecular Diagnostics, Merck KGaA, Beckman Coulter Inc., GNA Biosolutions, Asuragen, Inc, AutoGenomics, MolecularMD. The list includes the leading players, new entrants and start-ups.

Table of Contents

Chapter 1: Executive Summary

Chapter 2: Scope and Research Methodology

Chapter 3: Molecular Diagnostics - Changing-Industry Dynamics

  • 3.1. Increasing market penetration of molecular diagnostics in precision medicine industry
  • 3.2. Increasing demand for molecular diagnostics in emerging markets due to advancement in molecular techniques and diagnostics test

Chapter 4: Latest Organic and Inorganic Developments in Molecular Diagnostics in Healthcare

  • Inorganic Developments mentioned in this report are: Acquisitions, Mergers, Investments, Funding and Collaboration

Chapter 5: FDA Rules and Regulations Restraining Factors in Molecular Diagnostics

Chapter 6: Molecular Diagnostics for Applications: Infectious Disease, Oncology, Genetic Testing, Blood Screening

Chapter 7: Molecular Diagnostics Technology Analysis

  • 7.1. Fast and inexpensive polymerase chain reaction (PCR) technology used to amplify small segments of DNA
  • 7.2. Fluorescence in situ hybridization (FISH) a laboratory technique for detecting and locating a specific DNA sequence on a chromosome
  • 7.3. Sequencing (DNA & NGS) including genomics, proteomics, transcriptomics, metabolomics
  • 7.4. Microarray technology used for genotyping and determination of disease-relevant genes or agents causing diseases
  • 7.5. Isothermal Nucleic Acid Amplification Technology (INAAT) high on demand especially for Clinical application
  • 7.6. Other technologies includes: Electrophoresis, Mass spectroscopy and Flow cytometry

Chapter 8: Competition Assessment: Competitive Landscape in Molecular Diagnostics-

  • 8.1. Molecular Diagnostics Market share analysis by Products & Services offered by the Leading Companies
  • 8.2. Region wise market share analysis of Molecular Diagnostics Market
  • 8.3. Latest Technologies offered by the competitors in Molecular Diagnostics Market
  • 8.4. Latest Developments such as partnerships, collaboration, mergers & acquisitions, funding by the competitors in molecular Diagnostics market
  • 8.5. Leading Players in Molecular Diagnostics Market mentioned in report: Roche Diagnostics, Qiagen, Becton Dickinson (BD), Abbott Laboratories, Hologic (includes Gen-Probe), Agilent Technologies, Cepheid, Siemens Healthcare, BioMerieux, Quest Diagnostics Incorporated

Chapter 9: Appendix

  • 9.1. References
  • 9.2. Excerpt of interviews with leading industry players